Assembly Bill 54 aims to amend the statutes related to the Medical Assistance program by creating a new section, 49.45 (9o), which specifically addresses the utilization management controls for antipsychotic prescription drugs. The bill prohibits the Department of Health Services (DHS) from imposing any utilization management controls on prescription drugs that are both approved by the federal Food and Drug Administration (FDA) and classified as antipsychotic. Utilization management controls are defined as formal techniques used to assess the medical necessity, appropriateness, efficacy, or efficiency of prescription drugs, including methods such as prior authorization and step therapy protocols.

By enacting this bill, the legislature seeks to ensure that individuals receiving Medical Assistance, particularly those requiring antipsychotic medications, have better access to necessary treatments without the barriers typically imposed by utilization management practices. This change reflects a commitment to improving healthcare access for vulnerable populations in Wisconsin, particularly those with mental health needs.